VAS
AZN icon

Valicenti Advisory Services’s AstraZeneca AZN Stock Holding History

Valicenti Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.54M Buy
34,485
+3,300
+11% +$621K 1.23% 24
2026
Q1 		$6.15M Buy
31,185
+287
+0.9% +$55.3K 1.34% 23
2025
Q4 		$5.68M Buy
30,898
+550
+2% +$96.5K 1.19% 26
2025
Q3 		$4.66M Sell
30,348
-7,647
-20% -$1.16M 1% 29
2025
Q2 		$5.31M Buy
37,995
+255
+0.7% +$35.7K 1.24% 25
2025
Q1 		$5.55M Buy
37,740
+47
+0.1% +$6.8K 1.43% 22
2024
Q4 		$4.94M Sell
37,693
-209
-0.6% -$29.3K 1.23% 26
2024
Q3 		$5.91M Buy
37,902
+635
+2% +$103K 1.52% 25
2024
Q2 		$5.81M Sell
37,267
-1,595
-4% -$240K 1.56% 19
2024
Q1 		$5.27M Buy
+38,862
New +$5.15M 1.47% 23

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Valicenti Advisory Services's AZN Position: Q2 2026 in Review

Valicenti Advisory Services increased its AstraZeneca (AZN) stake by 11% in Q2 2026, buying an estimated $621K and bringing the position to 34,485 shares worth $6.54M. The position accounts for 1.23% of the portfolio, ranked #24.

Valicenti Advisory Services first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. 290 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Valicenti Advisory Services held 34,485 shares of AstraZeneca worth $6.54M as of Q2 2026.
  • Valicenti Advisory Services bought 3,300 AstraZeneca shares in Q2 2026, an estimated $621K.
  • AstraZeneca made up 1.23% of Valicenti Advisory Services's portfolio in Q2 2026, its #24 holding.
  • Valicenti Advisory Services first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
  • 290 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Valicenti Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.